59 unknown, 51 completed, 24 recruiting, 7 not yet recruiting. 50 Not applicable, 30 Phase 2, 16 Phase 4, 8 Phase 1, 5 Phase 3.
Follow Jinling Hospital, China: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Aeromonas sp. MTB Phage Therapy for Pouchitis in Patients With Ulcerative Colitis (UC) MTB-targeted phage therapy - Pouchitis, UC - Ulcerative Colitis | Early Phase 1 | Not yet recruiting | Jinling Hospital, China | 12 | 2027-01-01 | 2026-10-22 |
| China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm Tumor resection followed by aneurysm treatment, Aneurysm treatment followed by tumor resection, Observation - Unruptured Intracranial Aneurysms, Pituitary Neuroendocrine Tumor | Active not recruiting | Cheng sen | 608 | 2026-10-20 | 2026-10-21 | |
| CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk PD-1/PD-L1 ICI + VEGFR-TKI, Treatment pause - Metastatic Clear Cell Renal Cell Carcinoma | Phase 2 | Recruiting | Jinling Hospital, China | 75 | 2026-06-16 | 2026-08-11 |
| Gastric Feeding for the Prevention of Stroke-Associated Pneumonia Post-Pyloric Feeding, Gastric Feeding - Stroke | Phase 4 | Not yet recruiting | Jinling Hospital, China | 174 | 2026-06-15 | 2026-06-05 |
| Gut Microbiota Modulation for Immunotherapy Resensitization in Advanced Renal Cell Carcinoma Toripalimab, Ipilimumab - Advanced RCC | Phase 2 | Recruiting | Jinling Hospital, China | 33 | 2026-06-01 | 2026-08-03 |
| Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors UDCA (Ursodeoxycholic acid), Placebo - Kidney Cancer | Phase 2 | Recruiting | Jinling Hospital, China | 162 | 2026-06-01 | 2026-10-15 |
| A Study on the Efficacy of Sodium Propionate Combined With Anti-PD-1 Immunotherapy in Gastric Cancer Sodium propionate - Gastric Cancer (GC) | Not applicable | Not yet recruiting | Jinling Hospital, China | 20 | 2026-05-30 | 2026-05-29 |
| Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma Toripalimab, Lenvatinib - Clear Cell RCC | Phase 2 | Recruiting | Jinling Hospital, China | 75 | 2026-05-06 | 2026-05-11 |
| Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration. GLP-1 Receptor Agonists - Short Bowel Syndrome (SBS), Intestinal Failure | Not applicable | Completed | Jinling Hospital, China | 20 | 2026-01-24 | 2026-07-14 |
| Peg IFNα-2b Therapy for Unresectable Mid to Late Stage HBV-HCC Combined Peg IFNα-2b treatment group - HBV-HCC, Unresectable Advanced HBV-related Liver Cancer | Not applicable | Recruiting | Jinling Hospital, China | 33 | 2025-12-26 | 2026-08-18 |
| Effect of Remote Ischemic Preconditioning on Early Neurological Deterioration in Acute Perforating Artery Infarction remote ischemic preconditioning, sham remote ischemic preconditioning - Ischemic Stroke, Remote Ischaemic Preconditioning | Not applicable | Recruiting | Jinling Hospital, China | 910 | 2025-12-11 | 2026-02-03 |
| Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer Adebrelimab, albumin-bound paclitaxel, Gemcitabine - Pancreatic Cancer, Neoadjuvant Therapy | Phase 2 | Not yet recruiting | Jinling Hospital, China | 30 | 2025-11-30 | 2025-11-18 |
| Sequential Transarterial Chemoembolization (TACE), Stereotactic Body Radiation Therapy (SBRT), and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma Treated With Donafenib Donafina, PD-1/PD-L1 inhibitor - Unresectable Hepatocellular Carcinoma | Phase 2 | Not yet recruiting | Jinling Hospital, China | 34 | 2025-11-30 | 2025-11-17 |
| Stepped-Wedge Cluster Randomized Trial of AI-Assisted CTA Detection for Intracranial Aneurysms in Regional Hospitals AI-Assisted CTA Interpretation, Standard CTA Interpretation - Intracranial Aneurysm, CT Angiography | Not applicable | Not yet recruiting | Jinling Hospital, China | 14400 | 2025-10-09 | 2025-08-20 |
| Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy Nephrectomy, Renal Cell Cancer | Recruiting | Jinling Hospital, China | 285 | 2025-09-01 | 2025-12-19 | |
| HMG Treatment Reduces Sperm DNA Fragmentation Human Menopausal Gonadotropin (hMG), Vitamin E - Sperm DNA Fragmentation | Phase 1 | Completed | Jinling Hospital, China | 114 | 2025-07-02 | 2026-10-14 |
| Mesenteric Surgical Margin for Crohn's Disease Endoscopic Recurrence mesentery-guided resection margin, traditional resection margin - Endoscopic Recurrence Rate, After Ileocolic Crohn 's Disease Surgery | Not applicable | Recruiting | Sixth Affiliated Hospital, Sun Yat-sen University | 172 | 2025-07-01 | 2025-07-15 |
| AI-Assisted MRE for Intestinal Fibrosis in Crohn's Disease Crohn Disease (CD) | Recruiting | Minhu Chen | 234 | 2025-06-03 | 2025-08-05 | |
| Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery Salt substitute - Kidney Tumors, CKD | Not applicable | Recruiting | Jinling Hospital, China | 200 | 2025-04-24 | 2025-12-15 |
| Specific Dietary Fibers May Enhance Colonic Adaptation in Short Bowel Syndrome Through Microbial and Metabolic Mechanisms That Drive Functional Compensation. Dietary fiber intervention - Short Bowel Syndrome | Not applicable | Completed | Jinling Hospital, China | 10 | 2025-02-05 | 2025-09-22 |
Showing 20 of 149. Sign in to see all of them.
Crohn Disease (16) · Carcinoma, Renal Cell (9) · Stomach Neoplasms (8) · Ischemic Stroke (6) · Short Bowel Syndrome (6) · Carcinoma, Non-Small-Cell Lung (4) · Kidney Neoplasms (4) · Pancreatitis (4) · Postoperative Complications (4) · Sepsis (4) · Carcinoma (3) · Fibrosis (3) · Inflammatory Bowel Diseases (3) · Intestinal Failure (3) · Intestinal Fistula (3)
Fecal Microbiota Transplantation (7) · Enteral Nutrition (5) · Pectins (4) · spartalizumab (4) · Anti-Bacterial Agents (3) · Saline Solution (3) · Surgical Procedures, Operative (3) · toripalimab (3) · Adrenal Cortex Hormones (2) · Azathioprine (2) · Cyclophosphamide (2) · Dexamethasone (2) · Enhanced Recovery After Surgery (2) · Epirubicin (2) · Etoposide (2)
China (133) · Spain (1) · Switzerland (1)
Xinfeng Liu, MD (7) · Xinying Wang, MD (7) · Ning Li, MD (6) · Jianfeng Gong, MD (4) · Longjiang Zhang, MD (3) · Bing Yao, PHD (2) · Cencen Wang, MD (2) · Cheng Zhou, MD (2) · Fangyu Wang (2) · Guangming Lu (2) · Guoli Li, M.D. (2) · Haiyan Fu, MD (2) · Hong Zhang, MD (2) · Jianan Ren, MD (2) · Jiayi Ding, PHD (2)
PMID 37300882, PMID 38369126, PMID 11812697, PMID 15155349, PMID 1568651, PMID 16480471, PMID 17377114, PMID 17560413, PMID 18728566, PMID 18931242, PMID 19672942, PMID 21688000, PMID 22072149, PMID 22227107, PMID 22313322, PMID 22327172, PMID 22352229, PMID 22752346, PMID 22844053, PMID 23091606, PMID 23133723, PMID 23431120, PMID 23674254, PMID 23676860, PMID 23845268, PMID 23896172, PMID 24183344, PMID 24354519, PMID 25331349, PMID 25528723, PMID 25986785, PMID 26200619, PMID 26445823, PMID 26514251, PMID 26871851, PMID 26880227, PMID 27809778, PMID 28000190, PMID 28745410, PMID 29971593, PMID 30243299, PMID 31900292, PMID 32085793, PMID 32154773, PMID 32502991, PMID 32767153, PMID 32969884, PMID 33219848, PMID 33425441, PMID 33749741